Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123569134 | 12356913 | 4 | F | 20160715 | 20160928 | 20160511 | 20160930 | PER | US-PFIZER INC-2016253250 | PFIZER | 61.00 | YR | M | Y | 89.00000 | KG | 20160930 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123569134 | 12356913 | 1 | PS | CELEBREX | CELECOXIB | 1 | Oral | 200 MG, 1X/DAY | U | C140333 | 20998 | 200 | MG | CAPSULE, HARD | QD | ||||
| 123569134 | 12356913 | 2 | SS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | UNK | D | 0 | ||||||||||
| 123569134 | 12356913 | 3 | C | RANITIDINE. | RANITIDINE | 1 | 150 MG, UNK (ONE TO TWO TIMES A DAY) | 0 | 150 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123569134 | 12356913 | 1 | Arthritis |
| 123569134 | 12356913 | 2 | Abdominal pain upper |
| 123569134 | 12356913 | 3 | Abdominal pain upper |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123569134 | 12356913 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123569134 | 12356913 | Abdominal pain upper | |
| 123569134 | 12356913 | Nephrolithiasis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |